A Focus on Neurology

Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide. 

Our products are developed by Moleac with scientific excellence and evidence-based approach.

Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide. 

Challenging the Boundaries Of The Possible.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY

NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.

Patients taking NeuroAid yearly

Awards

Countries with Exclusive Partnership

Shaping the Future of Neurological Care

David Picard, CEO of Moleac, shares insights on unmet needs in post-stroke care and the role of science in improving outcomes for neurological conditions.

Latest News

Mar 16 2026
News

The Gut-Brain Connection: Understanding Gastrointestinal Dysfunction After TBI

📰🧠🔬 TRAUMATIC BRAIN INJURY STUDY HIGHLIGHTS – Gastrointestinal disorders in traumatic brain injury: pathophysiology, risk factors, and interventions by Fu AY., et...
Mar 16 2026
News

Making a Difference: Our Continued Partnership with the Kythe Foundation

Since 2022, Moleac has proudly supported the Kythe Foundation (www.kythe.org), a non-profit organization dedicated to bringing hope to children with cancer and chronic...
Mar 11 2026
News

Innovation and Insights: Highlights from our Scientific Meeting in Larnaca

In February, Moleac held the NeuroAiD and Alzheimer’s Disease Scientific Meeting in Larnaca (Cyprus).

Mar 10 2026
News

Advancing Alzheimer’s Care: Key Insights from Our Recent Scientific Meeting in Singapore

We were honoured to host the Alzheimer’s Disease Scientific Meeting in Singapore, 7 March, which brought together leading experts from across the region.

Mar 09 2026
News

Brain Injury Awareness Month: Understanding the Global Impact of TBI

March is Brain Injury Awareness Month!

Mar 09 2026
News

Strengthening Partnerships Across Southeast Asia: Highlights from the 2026 Affiliates Convention

Wrapping up another inspiring Affiliates Convention in Singapore!

Mar 07 2026
News

Driving Innovation in Stroke Recovery: Highlights from the 6th World AVM Congress

Insightful exchanges at the 6ᵗʰ World AVM Congress in Singapore.

Mar 01 2026
News

Brain Injury Awareness Month: Supporting the Journey to Recovery

March is Brain Injury Awareness Month!

Feb 26 2026
News

Could Blood Lead Screening Play a Role in Stroke Prevention? New Insights from a US National Health Survey

📰🧠🔬 STROKE STUDY HIGHLIGHTS – Association between blood lead levels and stroke: Evidence from a US National Health Survey by Li J., et al.

Feb 24 2026
News

Moleac at the 6ᵗʰ World AVM Congress & SNVIS ASM 2026 in Singapore

We are pleased to announce our participation in the 6ᵗʰ World AVM Congress and SNVIS Annual Scientific Meeting 2026 in Singapore, taking place from 5–7 March...